Hydreight Announces Refiling of Interim Financial Statements

Rhea-AI Summary

Hydreight (OTCQB: HYDTF) refiled its condensed interim consolidated financial statements for the three months ended March 31, 2026 and 2025 on SEDAR+.

The refiling corrects revenue classification within segment disclosures in Note 16, but does not change total revenue, gross profit, net income, cash flows, or balance sheet amounts.

AI-generated analysis. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

VANCOUVER, BC and LAS VEGAS, June 2, 2026 /PRNewswire/ - Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a U.S.-focused digital health infrastructure platform, announces that it has refiled its condensed interim consolidated financial statements for the three months ended March 31, 2026 and 2025 on SEDAR+ to correct classification errors contained within the segment financial information and disaggregation of revenue disclosures included in Note 16 – Operating Segments, relating to pharmacy sales within the Mobile Medical Services and Virtual Healthcare – Direct to Consumer segments. The Company has also made certain other immaterial administrative edits.

The corrections relate to the classification of revenue between these revenue categories and do not impact total revenues, gross profit, net income, cash flows, balance sheet amounts, or any other previously reported financial results for the three months ended March 31, 2026 and 2025.

Accordingly, there are no changes to the Company's reported financial results for the three months ended March 31, 2026 and 2025.

The amended financial statements have been filed on SEDAR+ and are available under the Company's profile at www.sedarplus.ca. 

On behalf of the Board of Directors

Shane Madden
Director and Chief Executive Officer
Hydreight Technologies Inc.

About Hydreight Technologies Inc.
Hydreight Technologies Inc. is building one of the largest mobile clinic networks in the United States. Its proprietary, fully integrated platform has hosted a network of over 3,000 nurses, over 300 doctors and a pharmacy network through its doctor networks across all 50 states. The platform includes a built-in, easy-to-use suite of fully integrated tools for accounting, documentation, sales, inventory, booking and managing patient data, enabling licensed healthcare professionals to provide services directly to patients at home, office or hotel. Hydreight is bridging the gap between provider compliance and patient convenience, empowering nurses, med spa technicians and other licensed healthcare professionals. The Hydreight platform allows healthcare professionals to deliver services independently, on their own terms, or add mobile services to existing location-based operations. Hydreight has a 503B pharmacy network servicing all 50 states and is closely affiliated with a U.S. certified e-script and telemedicine provider network.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hydreight-announces-refiling-of-interim-financial-statements-302789389.html

SOURCE Hydreight Technologies Inc.

FAQ

Why did Hydreight (HYDTF) refile its interim financial statements for March 31, 2026 and 2025?

Hydreight refiled its interim statements to correct classification errors in segment revenue disclosures. According to Hydreight, the corrections affect pharmacy sales allocation between Mobile Medical Services and Virtual Healthcare – Direct to Consumer segments, without changing any previously reported financial results.

Do Hydreight’s refiled March 31, 2026 interim results change revenue or net income for HYDTF shareholders?

Hydreight stated that the refiling does not change total revenue, gross profit, net income, cash flows, or balance sheet figures. According to Hydreight, only the classification of revenue between specific segment categories was updated for disclosure purposes.

What specific disclosure corrections did Hydreight (TSXV: NURS, HYDTF) make in its refiled interim financials?

Hydreight corrected classification of pharmacy sales within segment information and disaggregation of revenue in Note 16 – Operating Segments. According to Hydreight, the adjustments relate to Mobile Medical Services and Virtual Healthcare – Direct to Consumer segments, plus other immaterial administrative edits.

How do Hydreight’s refiled interim financial statements impact prior quarters for HYDTF investors?

Hydreight indicated there is no impact on previously reported financial results for the three months ended March 31, 2026 and 2025. According to Hydreight, only segment revenue classifications and related disclosures were revised, leaving all key financial metrics unchanged.

Where can investors access Hydreight’s refiled interim financial statements for March 31, 2026?

Investors can access the refiled interim financial statements on SEDAR+. According to Hydreight, the amended documents are available under the company’s profile at www.sedarplus.ca for the periods ended March 31, 2026 and 2025.